Drug application
ESOMEPRAZOLE SODIUM (ESOMEPRAZOLE SODIUM)
Drugs@FDA ANDA 207181 · REGCON HOLDINGS
Key facts
| Drug name | ESOMEPRAZOLE SODIUM |
|---|---|
| Active ingredients | ESOMEPRAZOLE SODIUM |
| Application type | ANDA |
| Application number | 207181 |
| Company | REGCON HOLDINGS |
| Dosage forms | INJECTABLE, INTRAVENOUS |
| Strength | EQ 40MG BASE/VIAL |
| Marketing status | Prescription |
| TE codes | AP |
| Reference listed drug | No |
| Latest submission status date | Mar 6, 2017 |
At a glance
- 1–9 Submissions
- None Label versions
- 1–9 Products
- 1–9 Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.